| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/03/2007 | US20070098724 Methods of Treatment Using Vascular Occlusion in Combination with One or More Therapies |
| 05/03/2007 | US20070098720 Cd40-binding apc-activating molecules |
| 05/03/2007 | US20070098688 Polymer conjugates of interferon beta-1a and uses |
| 05/03/2007 | US20070098634 method of inhibiting the growth; inhibiting neoplastic cell growth; cancer |
| 05/03/2007 | DE10333509B4 Gegen VEGF gerichtete Erkennungsmoleküle und die Verwendung dieser Directed against VEGF recognition molecules and the use of these |
| 05/03/2007 | DE10148618B4 Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel Substituted N- (1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their preparation and use as medicaments |
| 05/03/2007 | CA2628015A1 Fixed ratio drug combination treatments for solid tumors |
| 05/03/2007 | CA2626879A1 Method for predicting efficacy of rar-.alpha. agonist |
| 05/03/2007 | CA2626375A1 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
| 05/03/2007 | CA2624221A1 Preventives/remedies for cancer |
| 05/03/2007 | CA2623879A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 05/03/2007 | CA2623360A1 Squaric acid derivatives as inhibitors of histone deacetylase |
| 05/03/2007 | CA2525255A1 Minimalist bzip proteins and uses thereof |
| 05/02/2007 | EP1780277A1 IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons |
| 05/02/2007 | EP1780276A1 Bone/joint disease sensitivity gene and use thereof |
| 05/02/2007 | EP1780273A1 Cell proliferation inhibitors containing anti-glypican 3 antibody |
| 05/02/2007 | EP1780270A1 A detoxifizyme having activity of transforming aflatoxin and the gene encodes thereof |
| 05/02/2007 | EP1780268A2 PSCA: Prostate stem cell antigen and uses thereof |
| 05/02/2007 | EP1780221A1 Anti-synoviolin antibody |
| 05/02/2007 | EP1780214A2 Combinatorial production of nucleotide and nucleoside analogues (XiTP) |
| 05/02/2007 | EP1780212A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE |
| 05/02/2007 | EP1779865A1 Use of human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 05/02/2007 | EP1778718A1 Inhibitors of iap |
| 05/02/2007 | EP1778694A1 Tetrahydroquinolines |
| 05/02/2007 | EP1778691A1 Hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl)-benzamide, methods for the production thereof, and use thereof as medicaments |
| 05/02/2007 | EP1778687A2 Fused ring heterocycle kinase modulators |
| 05/02/2007 | EP1778683A1 Thiophene derivatives, their manufacture and use as pharmaceutical agents |
| 05/02/2007 | EP1778681A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 05/02/2007 | EP1778663A1 (-)-epigallocatechin gallate derivatives for inhibiting proteasome |
| 05/02/2007 | EP1778656A1 Benzoxazepine derivatives as selective estrogen receptor modulators |
| 05/02/2007 | EP1778648A2 Compounds useful for inhibiting chk1 |
| 05/02/2007 | EP1778647A1 New derivatives of 4, 5, 6, 7-tetrabromobenzimidazole and method of their preparation |
| 05/02/2007 | EP1778640A1 Trifluoromethyl substituted benzamides as kinase inhibitors |
| 05/02/2007 | EP1778619A2 T type calcium channel inhibitors |
| 05/02/2007 | EP1778616A1 Alpha-ketoglutarates and their use as therapeutic agents |
| 05/02/2007 | EP1778288A2 Deuterium depleted water (ddw) used as adjuvant in cancer therapy for cytostatics toxicity reduction |
| 05/02/2007 | EP1778254A2 Prodrugs activated by rna-dependent dna-polymerases |
| 05/02/2007 | EP1778240A2 Dihydropteridinones for the treatment of cancer diseases |
| 05/02/2007 | EP1778238A1 Dihydropteridinone infusion solution having a long shelf life |
| 05/02/2007 | EP1778237A1 Use of aminopterin for treating cancer and inflammatory disorders |
| 05/02/2007 | EP1778228A2 Therapeutic compound and treatments |
| 05/02/2007 | EP1778215A1 Anticancer effect enhancer |
| 05/02/2007 | EP1778209A1 Methods and compositions for oral delivery of fts |
| 05/02/2007 | EP1605952B1 Use of 5-substituted nucleosides for reinforcing the apoptotic effect of cytostatic drugs |
| 05/02/2007 | EP1576160B1 Borrelidin-derivatives and their use in medicine |
| 05/02/2007 | EP1492766B1 Improved cc-1065 analog synthesis |
| 05/02/2007 | EP1470127B1 N, n'-dimethylated n-confused porphyrins |
| 05/02/2007 | EP1408952B1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 05/02/2007 | EP1365797B1 Antibodies modulating the upa/upar interaction and uses thereof |
| 05/02/2007 | EP1358184B1 N-(3,3-Dimethylindolin-6-yl){2-[(4-pyridylmethyl)amino}(3-pyridyl)}carboxamide and pharmaceutical compositions thereof. |
| 05/02/2007 | EP1346058B1 Adenoviral systems and the uses thereof |
| 05/02/2007 | EP1280826B1 Polypeptides for inhibiting april-mediated b- and t-cell proliferation. |
| 05/02/2007 | EP1261372B1 Method of treating cancer with anti-neurotrophin agents |
| 05/02/2007 | EP1226155B1 18-nor-steroids as selectively active estrogens |
| 05/02/2007 | EP1202734B1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 05/02/2007 | EP1032596B1 Lactalbumin production process |
| 05/02/2007 | EP1032405A4 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 05/02/2007 | EP0998305B1 Cytolysis of target cells by superantigen conjugates inducing t-cell activation |
| 05/02/2007 | EP0912085B1 Precise efficacy assay methods for active agents including chemotherapeutic agents |
| 05/02/2007 | EP0906426B1 Antibodies to the ed-b domain of fibronectin, their construction and uses |
| 05/02/2007 | CN2894699Y Film-coated tablet of norcantharidin |
| 05/02/2007 | CN1957084A Bone marrow-relevant cell participating the maintenance and/or repair of tissue |
| 05/02/2007 | CN1956991A Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof |
| 05/02/2007 | CN1956986A 6-substituted pyridoindolone derivatives, production method and therapeutic use thereof |
| 05/02/2007 | CN1956982A Selective inhibitors against Cdk4 and Cdk6 having aminothiazole skeleton |
| 05/02/2007 | CN1956966A Quinazoline derivatives and therapeutic use thereof |
| 05/02/2007 | CN1956960A Substituted quinoline derivatives as mitotic kinesin inhibitors |
| 05/02/2007 | CN1956725A Antineoplastic agent |
| 05/02/2007 | CN1956723A Sulfonylethyl phosphorodiamidates |
| 05/02/2007 | CN1955305A Method for preparing anthracene Ensamu bacterial |
| 05/02/2007 | CN1955280A Potency regeneration cell and culturing method thereof |
| 05/02/2007 | CN1955192A Protein for promoting erythrocyte growth factor activity and its use |
| 05/02/2007 | CN1955183A 20-bit esterified camptothecine derivate, its preparation method and drug composite and use |
| 05/02/2007 | CN1955180A 1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-IJ] quinoline derivatives as antipsychotic and antiobesity agents |
| 05/02/2007 | CN1955163A Cyclooxygenase-2 selection inhibitor and its medicine use |
| 05/02/2007 | CN1954870A Medical composite prepared by sarcandra and oldenlandia |
| 05/02/2007 | CN1954864A Life-saving pill for acute abdomen |
| 05/02/2007 | CN1954849A Antineoplastic medical composite compatibility with oldenlandia, ginseng and astragalus root |
| 05/02/2007 | CN1954845A Sarcandra compound medical composite and its preparation method |
| 05/02/2007 | CN1954840A Medical composite prepared by Gynostemma pentaphylla, American ginseng and astragalus root |
| 05/02/2007 | CN1954839A Medical composite prepared by caulis Marsdeniae Tenacissimae, ginseng and astragalus root |
| 05/02/2007 | CN1954838A Medical composite of antineoplastic |
| 05/02/2007 | CN1954836A Chinese traditional western compound medicine and its preparation method |
| 05/02/2007 | CN1954811A Oxaliplatin intravenous injection and its preparation method |
| 05/02/2007 | CN1954805A Application of resorcin compound for preparing antitumor medicine |
| 05/02/2007 | CN1954804A Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 05/02/2007 | CN1313617C Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 05/02/2007 | CN1313611C Novel tumor wilting matter 2 ligand gene, its expressed tumor wilting matter and its preparation method |
| 05/02/2007 | CN1313603C Human ovary carcinoma resisting monoclonal antibody hybridoma cell line and its monoclonal antibody and application |
| 05/02/2007 | CN1313489C GP thymosin alpha 1 and preparation method |
| 05/02/2007 | CN1313484C 12 amino acid analog epi-position of human B cell specificity membrane molecule CD20 and polypeptide epi-position vaccine configurated by said analog epi-position |
| 05/02/2007 | CN1313481C Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof |
| 05/02/2007 | CN1313464C Substituted alkylamine derivatives, preparing method thereof, composition comprising same and use thereof |
| 05/02/2007 | CN1313463C Benzopyran derivatives substituted with secondary amines including imidazole, their preparation and pharmaceutical compositions containing them |
| 05/02/2007 | CN1313462C New 3-(4-oxygen-4H-benzopyranyl-2-base)-(1H)-quinoline-4-ketone derivant, its preparing method and drug compositions containing them |
| 05/02/2007 | CN1313459C Total flavone glycoside extract of Radix scutellariae, Rodix scutellariae monomer flavone glycoside, its preparation and use |
| 05/02/2007 | CN1313449C New quinazoline hind derivative, medicinal composition containing same and their use |
| 05/02/2007 | CN1313448C Metalloproteinase inhibitors |
| 05/02/2007 | CN1313433C Novel dibenzocyclooctenes lignan and its preparation method and use |
| 05/02/2007 | CN1313161C Radiative immune guiding operating medicine of colorectal disease and preparation method thereof |